1.180SEK-2.88%Mkt Cap: 113.00M SEKP/E: —Last update: 2026-05-13
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-1.07
PEG—
P/B0.72
P/S8.17
EV/EBITDA-1.81
EV/Revenue5.02
EPS (TTM)-1.14
EPS (Forward)-1.10
Cash Flow & Leverage
FCF Yield-24.13%
FCF Margin-197.18%
Operating CF-31.87M SEK
CapEx (TTM)14.09M SEK
Net Debt/EBITDA1.14
Net Debt-43.55M SEK
Technical
SMA 501.171 (+0.8%)
SMA 2001.505 (-21.6%)
Beta0.38
S&P 52W Chg24.23%
Avg Vol (30d)82.94K
Avg Vol (10d)39.63K
Technical Indicators
RSI (14)49.7
MACD0.0070
MACD Signal0.0094
MACD Hist.-0.0024
BB Upper1.245 SEK
BB Middle1.185 SEK
BB Lower1.126 SEK
BB Width10.04%
ATR (14)0.0625 SEK
Vol Ratio (20d)0.21x
52W Range
0.906015% of range2.790
52W High2.790 SEK
52W Low0.9060 SEK
Profitability
Gross Margin1042.65%
EBITDA Margin-277.05%
Profit Margin-3925.50%
Oper. Margin-188.10%
ROE-36.77%
ROA-33.08%
Revenue Growth-14.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio3.70
Quick Ratio3.70
Book Value/Sh1.640 SEK
Cash/Share0.5120 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.96.17M
Float92.60M
Insiders48.90%
Institutions34.06%
Analyst Consensus
Rating—
Target (Mean)0.8000 SEK
Target Range0.8000 SEK – 0.8000 SEK
# Analysts1
Company
Market Cap113.00M SEK
Enterprise Value69.45M SEK
Revenue (TTM)13.83M SEK
Gross Profit11.52M SEK
Net Income (TTM)-43.36M SEK
Revenue/Share0.2660 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
Last Price1.180 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—